Premaitha Health PLC | Income Statement

Fiscal year is April-March. All values GBP Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
257.70
62.10
132.30
2,452.40
3,078.70
Cost of Goods Sold (COGS) incl. D&A
2,758.80
437.60
258.40
1,751.40
1,796.30
Gross Income
2,501.10
375.50
126.10
701.00
1,282.40
SG&A Expense
2,459.90
1,286.20
5,995.80
7,193.00
8,995.40
EBIT
4,961.00
1,661.60
-
6,492.00
7,713.00
Unusual Expense
-
3,273.10
2,115.30
5,834.30
689.20
Non Operating Income/Expense
-
-
98.70
-
7.30
Interest Expense
-
-
-
99.20
292.20
Pretax Income
4,959.00
4,933.40
8,248.00
12,410.60
8,656.40
Income Tax
294.80
-
800.50
333.70
797.40
Consolidated Net Income
4,664.20
4,933.40
7,447.50
12,076.90
7,859.00
Net Income
4,664.20
4,933.40
7,447.50
12,076.90
7,859.00
Net Income After Extraordinaries
4,664.20
4,933.40
7,447.50
12,076.90
7,859.00
Net Income Available to Common
4,664.20
4,933.40
7,447.50
12,076.90
7,859.00
EPS (Basic)
0.38
0.24
0.05
0.06
0.03
Basic Shares Outstanding
12,192.70
20,142.30
151,891.70
218,109.10
236,277.80
EPS (Diluted)
0.38
0.24
0.04
0.04
0.03
Diluted Shares Outstanding
12,192.70
20,142.30
185,199.50
277,102.20
236,277.80
EBITDA
2,757.40
1,418.40
5,863.60
5,934.70
6,976.00
Non-Operating Interest Income
2.00
1.30
88.00
15.00
45.40

About Premaitha Health

View Profile
Address
Rutherford House
Manchester Greater Manchester M15 6SZ
United Kingdom
Employees -
Website http://premaitha.com/
Updated 09/14/2018
Premaitha Health Plc engages in the manufacture, development and sale of molecular diagnostic products. Its product IONA test, which is marked as non-invasive in vitro diagnostic product for prenatal screening. The company was founded in 2013 and is headquartered in Manchester, the United Kingdom.